Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Sell
3,860
-241
-6% -$28.2K 0.19% 55
2026
Q1
$493K Sell
4,101
-184
-4% -$21.2K 0.22% 56
2025
Q4
$451K Buy
+4,285
New +$402K 0.23% 50

Other funds holding MRK

Bravera Wealth's MRK Position: Q2 2026 in Review

Bravera Wealth reduced its Merck (MRK) stake by 5.9% in Q2 2026, selling an estimated $28.2K and leaving 3,860 shares worth $496K. The position accounts for 0.19% of the portfolio, ranked #55.

Bravera Wealth first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bravera Wealth held 3,860 shares of Merck worth $496K as of Q2 2026.
  • Bravera Wealth sold 241 Merck shares in Q2 2026, an estimated $28.2K.
  • Merck made up 0.19% of Bravera Wealth's portfolio in Q2 2026, its #55 holding.
  • Bravera Wealth first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.